questionsmedicales.fr
Glucides
Hétérosides
Lincosamides
Lincosamides : Questions médicales fréquentes
Diagnostic
5
Infections bactériennes
Culture bactérienne
Sensibilité aux antibiotiques
Tests de laboratoire
Bactéries Gram-positives
Anaérobies
Résistance bactérienne
Tests de sensibilité
Symptômes d'infection
Fièvre
Symptômes
5
Effets secondaires
Nausées
Allergies médicamenteuses
Éruptions cutanées
Infection
Écoulement purulent
Troubles digestifs
Diarrhée
Prévention
5
Prévention des infections
Hygiène
Hygiène
Prévention des infections
Vaccination
Prévention des infections
Résistance aux antibiotiques
Utilisation des antibiotiques
Traitements
5
Administration médicamenteuse
Voie intraveineuse
Durée du traitement
Infections bactériennes
Interactions médicamenteuses
Antibiotiques
Complications
5
Colite pseudomembraneuse
Complications
Infections secondaires
Flore bactérienne
Réaction allergique
Consultation médicale
Fonction hépatique
Complications
Complications graves
Douleurs abdominales
Facteurs de risque
5
Immunodépression
Infections bactériennes
Personnes âgées
Vulnérabilité
Maladies chroniques
Diabète
Voyages
Agents pathogènes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lincosamides : Questions médicales les plus fréquentes",
"headline": "Lincosamides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lincosamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-08",
"dateModified": "2026-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lincosamides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hétérosides",
"url": "https://questionsmedicales.fr/mesh/D006027",
"about": {
"@type": "MedicalCondition",
"name": "Hétérosides",
"code": {
"@type": "MedicalCode",
"code": "D006027",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.408"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lincomycine",
"alternateName": "Lincomycin",
"url": "https://questionsmedicales.fr/mesh/D008034",
"about": {
"@type": "MedicalCondition",
"name": "Lincomycine",
"code": {
"@type": "MedicalCode",
"code": "D008034",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.408.471.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Clindamycine",
"alternateName": "Clindamycin",
"url": "https://questionsmedicales.fr/mesh/D002981",
"about": {
"@type": "MedicalCondition",
"name": "Clindamycine",
"code": {
"@type": "MedicalCode",
"code": "D002981",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.408.471.500.125"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lincosamides",
"alternateName": "Lincosamides",
"code": {
"@type": "MedicalCode",
"code": "D055231",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takahiro Mori",
"url": "https://questionsmedicales.fr/author/Takahiro%20Mori",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan."
}
},
{
"@type": "Person",
"name": "Ikuro Abe",
"url": "https://questionsmedicales.fr/author/Ikuro%20Abe",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan."
}
},
{
"@type": "Person",
"name": "Prakash M Halami",
"url": "https://questionsmedicales.fr/author/Prakash%20M%20Halami",
"affiliation": {
"@type": "Organization",
"name": "Microbiology & Fermentation Technology Department, CSIR-Central Food Technological Research Institute, Mysuru, India."
}
},
{
"@type": "Person",
"name": "Simon Smith",
"url": "https://questionsmedicales.fr/author/Simon%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia."
}
},
{
"@type": "Person",
"name": "Josh Hanson",
"url": "https://questionsmedicales.fr/author/Josh%20Hanson",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Lincosamide Antibiotics: Structure, Activity, and Biosynthesis.",
"datePublished": "2024-01-15",
"url": "https://questionsmedicales.fr/article/38165257",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cbic.202300840"
}
},
{
"@type": "ScholarlyArticle",
"name": "Structure-Function Analysis of the S-Glycosylation Reaction in the Biosynthesis of Lincosamide Antibiotics.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37222528",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/anie.202304989"
}
},
{
"@type": "ScholarlyArticle",
"name": "Macrolide-Lincosamide Resistance and Virulence Genes in",
"datePublished": "2023-10-15",
"url": "https://questionsmedicales.fr/article/38024553",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.30699/IJP.2023.1987077.3049"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent development and fighting strategies for lincosamide antibiotic resistance.",
"datePublished": "2024-04-18",
"url": "https://questionsmedicales.fr/article/38634634",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/cmr.00161-23"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microbial hitchhikers harbouring antimicrobial-resistance genes in the riverine plastisphere.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/37908022",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40168-023-01662-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Glucides",
"item": "https://questionsmedicales.fr/mesh/D002241"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hétérosides",
"item": "https://questionsmedicales.fr/mesh/D006027"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lincosamides",
"item": "https://questionsmedicales.fr/mesh/D055231"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lincosamides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lincosamides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lincosamides",
"description": "Comment diagnostiquer une infection bactérienne ?\nQuels tests sont utilisés pour les lincosamides ?\nLes lincosamides sont-ils efficaces contre toutes les bactéries ?\nComment évaluer la résistance aux lincosamides ?\nQuels symptômes indiquent une infection nécessitant des lincosamides ?",
"url": "https://questionsmedicales.fr/mesh/D055231#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lincosamides",
"description": "Quels sont les effets secondaires des lincosamides ?\nLes lincosamides causent-ils des allergies ?\nQuels signes d'infection nécessitent un traitement par lincosamides ?\nLes lincosamides provoquent-ils des troubles digestifs ?\nComment reconnaître une surinfection lors d'un traitement ?",
"url": "https://questionsmedicales.fr/mesh/D055231#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lincosamides",
"description": "Comment prévenir les infections nécessitant des lincosamides ?\nLes lincosamides peuvent-ils être utilisés en prophylaxie ?\nQuelles mesures d'hygiène sont recommandées ?\nLes vaccinations aident-elles à réduire les infections ?\nComment éviter la résistance aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D055231#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lincosamides",
"description": "Comment administrer les lincosamides ?\nQuelle est la durée du traitement par lincosamides ?\nLes lincosamides sont-ils utilisés en pédiatrie ?\nPeut-on combiner les lincosamides avec d'autres antibiotiques ?\nQuels antibiotiques sont similaires aux lincosamides ?",
"url": "https://questionsmedicales.fr/mesh/D055231#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lincosamides",
"description": "Quelles complications peuvent survenir avec les lincosamides ?\nLes lincosamides peuvent-ils causer des infections secondaires ?\nComment gérer une réaction allergique aux lincosamides ?\nLes lincosamides peuvent-ils affecter le foie ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D055231#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lincosamides",
"description": "Qui est à risque d'infections nécessitant des lincosamides ?\nLes personnes âgées sont-elles plus à risque ?\nQuels comportements augmentent le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D055231#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection bactérienne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des tests de culture et des analyses de sang."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les lincosamides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques sont réalisés pour déterminer l'efficacité."
}
},
{
"@type": "Question",
"name": "Les lincosamides sont-ils efficaces contre toutes les bactéries ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils sont principalement efficaces contre les bactéries Gram-positives et certains anaérobies."
}
},
{
"@type": "Question",
"name": "Comment évaluer la résistance aux lincosamides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La résistance est évaluée par des tests de sensibilité en laboratoire."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection nécessitant des lincosamides ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, rougeur ou gonflement peuvent indiquer une infection bactérienne."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des lincosamides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des nausées, diarrhées et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les lincosamides causent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques peuvent survenir, comme des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection nécessitent un traitement par lincosamides ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, douleur et écoulement purulent sont des signes d'infection."
}
},
{
"@type": "Question",
"name": "Les lincosamides provoquent-ils des troubles digestifs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles digestifs comme la diarrhée peuvent survenir avec leur utilisation."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une surinfection lors d'un traitement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surinfection se manifeste par une aggravation des symptômes ou de nouveaux symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections nécessitant des lincosamides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et se faire vacciner contre certaines infections."
}
},
{
"@type": "Question",
"name": "Les lincosamides peuvent-ils être utilisés en prophylaxie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être prescrits en prophylaxie dans certains cas, comme avant une chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à réduire les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections bactériennes spécifiques."
}
},
{
"@type": "Question",
"name": "Comment éviter la résistance aux antibiotiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser les antibiotiques uniquement lorsque nécessaire et suivre les prescriptions."
}
},
{
"@type": "Question",
"name": "Comment administrer les lincosamides ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être administrés par voie orale ou intraveineuse selon l'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement par lincosamides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée varie selon l'infection, généralement de 7 à 14 jours."
}
},
{
"@type": "Question",
"name": "Les lincosamides sont-ils utilisés en pédiatrie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés chez les enfants, mais avec précaution."
}
},
{
"@type": "Question",
"name": "Peut-on combiner les lincosamides avec d'autres antibiotiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais cela doit être fait sous supervision médicale pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quels antibiotiques sont similaires aux lincosamides ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les macrolides et les tétracyclines ont des mécanismes d'action similaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les lincosamides ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la colite pseudomembraneuse peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les lincosamides peuvent-ils causer des infections secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent perturber la flore bactérienne et entraîner des infections secondaires."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique aux lincosamides ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser le traitement et consulter un médecin pour un traitement approprié."
}
},
{
"@type": "Question",
"name": "Les lincosamides peuvent-ils affecter le foie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests de fonction hépatique peuvent être nécessaires en cas de traitement prolongé."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales sévères, des vomissements ou des éruptions cutanées étendues."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'infections nécessitant des lincosamides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou ayant des antécédents d'infections bactériennes."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent plus vulnérables aux infections et complications."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, une mauvaise hygiène et le manque de vaccination augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à des agents pathogènes inconnus et à des infections."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan.
PRESTO, Japan Science and Technology Agency, 4-1-8, Honcho, Kawaguchi, Saitama, 332-0012, Japan.
Publications dans "Lincosamides" :
2 publications dans cette catégorie
Affiliations :
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan.
Publications dans "Lincosamides" :
2 publications dans cette catégorie
Affiliations :
Microbiology & Fermentation Technology Department, CSIR-Central Food Technological Research Institute, Mysuru, India.
Publications dans "Lincosamides" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia.
Publications dans "Lincosamides" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia.
Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Publications dans "Lincosamides" :
2 publications dans cette catégorie
Affiliations :
CHU de Caen, Service de Microbiologie, Caen, F-14033, France; Université de Caen Normandie, EA4655 (équipe "Antibio-résistance"), Caen, F-14032, France.
Publications dans "Lincosamides" :
2 publications dans cette catégorie
Affiliations :
CHU Rennes, Service de Bactériologie et Hygiène Hospitalière, Rennes, F-35033, France; CNR de la Résistance aux Antibiotiques, Rennes, F-35033, France. Electronic address: vincent.cattoir@chu-rennes.fr.
Publications dans "Lincosamides" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8 St., 02-786 Warsaw, Poland.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8 St., 02-786 Warsaw, Poland.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8 St., 02-786 Warsaw, Poland.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8 St., 02-786 Warsaw, Poland.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8 St., 02-786 Warsaw, Poland.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Infectious Diseases, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Publications dans "Lincosamides" :
1 publication dans cette catégorie
Affiliations :
Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Publications dans "Lincosamides" :
Lincosamides are naturally occurring antibiotics isolated from Streptomyces sp. Currently, lincomycin A and its semisynthetic analogue clindamycin are used as clinical drugs. Due to their unique struc...
The S-glycosyltransferase LmbT, involved in the biosynthesis of lincomycin A, is the only known enzyme that catalyzes the enzymatic incorporation of rare amino acid L-ergothioneine (EGT) into secondar...
A total of 118 clinical...
In total, 49.1% (58/118) and 44% (52/118) of the isolates were resistant to erythromycin and clindamycin, respectively. Overall, 13.5% (16/118) of the isolates showed the iMLSB resistance phenotype. T...
A high frequency of macrolide- and lincosamide-resistant...
SUMMARYLincosamides constitute an important class of antibiotics used against a wide range of pathogens, including methicillin-resistant...
The widespread nature of plastic pollution has given rise to wide scientific and social concern regarding the capacity of these materials to serve as vectors for pathogenic bacteria and reservoirs for...
We show that plastics support a taxonomically distinct microbiome containing potential pathogens and ARGs. While the plastisphere was similar to those biofilms that grew on wood, they were distinct fr...
Our results provide insights into the capacity of the riverine plastisphere to harbour a distinct set of potentially pathogenic bacteria and function as a reservoir of ARGs. The environmental impact t...
The emergence of Methicillin-resistant Staphylococcus aureus and its ability to confer cross-resistance to macrolide-lincosamide-streptogramin B has complicated the treatment against it. Gene-based st...
S. aureus isolated from different clinical samples was identified by standard microbiological procedures (Gram-staining, colony morphology, and different biochemical tests). Methicillin-resistant and ...
Among 120 S. aureus isolates, 51.67% (n=62) were MRSA, and the prevalence of inducibly-resistant, constitutively-resistant and Macrolide-Streptogramin phenotypes were 15.83% (n=19), 28.33% (n=34) and ...
Macrolides-Lincosamide-Streptogramin B resistance was predominant among methicillin-resistant S. aureus. While all isolates with inducible clindamycin resistance harbored mecA gene, most of them also ...
Knowing about the antibiotic resistance, serotypes, and virulence-associated genes of Group B Streptococcus for epidemiological and vaccine development is very important. We have determined antimicrob...
Hypersensitivity reactions (HSR) are reported for the macrolides, lincosamides, and streptogramins (MLS) antibiotic family. Data about cross-reactivity among and between MLS remain scarce or controver...
The aim of this study was to provide an overview of hypersensitivity cross-reactions among MLSs based on data extracted from the French National Pharmacovigilance Database (FPVD)....
Cases of HSR to MLSs reported between January 1985 and December 2019 were extracted from the FPVD using standardized MedDRA queries (SMQ). Cases including an allergological test involving multiple MLS...
Of the 8394 cases reviewed, 149 were included. HSR mainly involved pristinamycin (n = 83; 53.2%) and spiramycin (n = 31; 19.9%). HSR to MLS was immediate in 54 cases and delayed in 94 cases. Skin test...
This study highlights the possibility of cross-reactivity among and between MLSs. Dermatologists and allergologists managing patients with HSR to MLSs should be aware of a risk of cross-reactivity amo...
Existing recommended first-line antibiotic agents for MRSA pneumonia have several shortcomings. We reviewed 29 cases of community- and hospital-acquired MRSA pneumonia managed at our hospital. Lincosa...
Antimicrobial resistance is a global pandemic that poses a major threat to vision health as ocular bacteria, especially methicillin-resistant S. aureus (MRSA), are becoming increasingly resistant to f...
Antimicrobial susceptibility testing was performed by broth microdilution for two novel synthetic lincosamides (iboxamycin and cresomycin) and 8 comparator antibiotics against a collection of 50 genom...
Both drugs were active against widespread MRSA clonal complexes CC8 and CC5. The MIC...
Our results demonstrate that iboxamycin and cresomycin display potent in vitro activity against ocular MRSA isolates, including multidrug-resistant isolates harboring erm genes....